MO HB1506

Health benefit plans covering cancer chemotherapy cannot require higher co-payments, deductibles, or coinsurance for oral anticancer medications than for intravenously administered or injected chemotherapy medications.

Health carriers cannot comply with this requirement by increasing out-of-pocket costs for intravenously administered or injected cancer chemotherapy agents.

Health carriers may still require prior authorization and other appropriate utilization controls for chemotherapy coverage.

Supplemental insurance policies, Medicare supplements, long-term care policies, and short-term major medical policies of six months or less are exempt from this requirement.

Applies to health benefit plans and health carriers as defined in section 376.1350 of Missouri law.